SV

Street Verdict

Analyst Scorecard

GIANLIFE.BO · BSE

Gian Life Care Limited

₹4.29

+4.89% (+₹0.2)

Prev. close

₹4.09

Volume

7,967

As of

20 Nov 2026

Price history

₹4.29-₹0.65 (-13.16%) · 3M
18 Aug 2026 → 20 Nov 2026
4.24.44.64.818 Aug09 Sept06 Oct29 Oct20 Nov
Daily closes · updates after each session

Analyst sentiment

No analyst stances in this range

0 analyst stances · last 90 days · one per analyst

Try a wider range — no analyst has covered this yet.

Explore by date range →

Analyst opinions

No analyst calls on Gian Life Care Limited yet.

Fundamentals

About Gian Life Care Limited

Gian Life Care Limited provides diagnostic and related healthcare tests and services primarily in India. It offers patient diagnosis, as well as prevention and wellness diagnosis services. The company also provides various types of tests, such as biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, etc. It serves patients, healthcare providers, hospitals, and corporate customers. The company was incorporated in 2018 and is based in Kanpur, India.

Details

Sector

Healthcare

Industry

Diagnostics & Research

CEO

Mr. Arun Kumar Gupta

Headquarters

Kanpur

Employees

24

Key stats

Market cap

₹4.40 Cr

Dividend yield

0.00%

EPS (TTM)

₹-0.94

Beta (1Y · daily vs NIFTY 50)

0.41

Beta (5Y · monthly vs NIFTY 50)

0.80

Shares float

50.92 L

EPS · quarter ended Dec 2025

₹0.10

Financial Performance

01 · Financials

-10 Cr0 Cr10 Cr20 Cr₹-20%0%20%40%FY21FY22FY23FY24FY25
RevenueNet incomeEBITDANet income ÷ revenue

02 · Earnings Per Share (EPS)

-2.502.55₹FY21FY22FY23FY24FY25

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based · pre-FY23 not filed in verifiable form

-100%0%100%200%FY21FY22FY23FY24FY25
SalesFixed assetsTrade receivablesInventory

05 · Capital Structure & Asset Utilization

Pre-FY23 not filed in verifiable form

0 Cr10 Cr20 Cr30 Cr40 Cr₹0×0.2×0.4×0.6×FY22FY23FY24FY25
Total assetsTotal debtDebt / equityAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

Pre-FY23 not filed in verifiable form

0 Cr10 Cr20 Cr30 Cr40 Cr₹FY21FY22FY23FY24FY25
Fixed assetsCurrent assetsOther assets

07 · Debt Level & Coverage

Pre-FY23 not filed in verifiable form

-5 Cr0 Cr5 Cr10 Cr₹FY21FY22FY23FY24FY25
DebtFree cash flowCash & equivalents

08 · Profit & Loss

Annual

Line itemFY21FY22FY23FY24FY25
₹10.46 Cr₹15.93 Cr₹11.92 Cr₹13.12 Cr₹6.63 Cr
EBITDA
₹3.34 Cr₹6.53 Cr₹2.52 Cr₹6.74 Cr₹1.18 Cr
₹2.02 Cr₹4.37 Cr₹1.06 Cr₹4.15 Cr₹-3.72 L
Diluted EPS
₹4.29₹4.23₹1.03₹4.01₹-0.04

Depreciation & amortisation, Pretax income, Tax provision, Interest expense have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

09 · Balance Sheet

Annual

Line itemFY21FY22FY23FY24FY25
—₹23.06 Cr₹28.24 Cr₹32.64 Cr₹35.93 Cr
—₹4.52 Cr₹4.58 Cr₹4.88 Cr₹5.84 Cr
Stockholders' equity
—₹14.03 Cr₹15.12 Cr₹19.26 Cr₹19.22 Cr

Total assets, Current assets, Trade receivables, Cash & equivalents, Non-current assets, Fixed assets, Total debt, Long-term debt, Current (short-term) debt, Others, Stockholders' equity have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.

10 · Cash Flow Statement

Annual

Line itemFY21FY22FY23FY24FY25
—₹1.32 Cr₹2.22 Cr₹69.55 L₹26.53 L
Investing cash flow
—₹-46.86 L₹-94.03 L₹-31.53 L₹25.42 L
—₹1.49 Cr₹-36.64 L₹-16.03 L₹45.26 L
Capital expenditure
—₹-95.69 L₹-1.63 Cr₹-98.36 L₹-1.06 L
End cash position
—₹4.85 Cr₹5.77 Cr₹5.99 Cr₹6.96 Cr

Operating cash flow, Depreciation & amortization, Change in working capital, Investing cash flow, Financing cash flow, Debt issued, Debt repaid, Capital expenditure, End cash position have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source has no quarterly cash-flow-statement coverage.

12 · Peer Comparison

Healthcare

Company
Sun Pharmaceutical Industries Limited₹4.25 L Cr₹1,769.938.85.0913.7%0.06+11.9%+3.7%
Divi's Laboratories Limited₹2.66 L Cr₹10,037.590.815.8515.3%0.00+12.3%+47.5%
Torrent Pharmaceuticals Limited₹1.79 L Cr₹4,738.579.421.3125.8%1.79+21.5%+32.5%
Laurus Labs Limited₹1.27 L Cr₹2,34894.823.9416.8%0.48+22.0%+146.2%
Apollo Hospitals Enterprise Limited₹1.23 L Cr₹8,599.558.812.9520.5%0.90+15.7%+10.1%
Zydus Lifesciences Limited₹1.19 L Cr₹1,188.126.74.4018.6%0.46+18.4%+22.3%
Lenskart Solutions Limited₹1.16 L Cr₹689.7181.413.305.6%0.35+35.4%—
Dr. Reddy's Laboratories Limited₹1.14 L Cr₹1,37440.63.0211.4%0.21+3.2%+14.5%
Cipla Limited₹1.13 L Cr₹1,40238.93.2711.3%0.02+2.1%-6.7%
Mankind Pharma Limited₹1.03 L Cr₹2,47545.96.3111.7%0.39+17.0%+3.1%
Aurobindo Pharma Limited₹98,101.93 Cr₹1,70526.62.599.2%0.21+6.4%+48.4%
Gian Life Care Limited₹4.43 Cr₹4.25—0.23-0.2%0.30-49.5%-65.2%

Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.

No stock news captured yet.